» Articles » PMID: 14998749

Urinary Levels of Seven Phthalate Metabolites in the U.S. Population from the National Health and Nutrition Examination Survey (NHANES) 1999-2000

Overview
Date 2004 Mar 5
PMID 14998749
Citations 370
Authors
Affiliations
Soon will be listed here.
Abstract

We measured the urinary monoester metabolites of seven commonly used phthalates in approximately 2,540 samples collected from participants of the National Health and Nutrition Examination Survey (NHANES), 1999-2000, who were greater than or equal to 6 years of age. We found detectable levels of metabolites monoethyl phthalate (MEP), monobutyl phthalate (MBP), monobenzyl phthalate (MBzP), and mono-(2-ethylhexyl) phthalate (MEHP) in > 75% of the samples, suggesting widespread exposure in the United States to diethyl phthalate, dibutyl phthalate or diisobutylphthalate, benzylbutyl phthalate, and di-(2-ethylhexyl) phthalate, respectively. We infrequently detected monoisononyl phthalate, mono-cyclohexyl phthalate, and mono-n-octyl phthalate, suggesting that human exposures to di-isononyl phthalate, dioctylphthalate, and dicyclohexyl phthalate, respectively, are lower than those listed above, or the pathways, routes of exposure, or pharmacokinetic factors such as absorption, distribution, metabolism, and elimination are different. Non-Hispanic blacks had significantly higher concentrations of MEP than did Mexican Americans and non-Hispanic whites. Compared with adolescents and adults, children had significantly higher levels of MBP, MBzP, and MEHP but had significantly lower concentrations of MEP. Females had significantly higher concentrations of MEP and MBzP than did males, but similar MEHP levels. Of particular interest, females of all ages had significantly higher concentrations of the reproductive toxicant MBP than did males of all ages; however, women of reproductive age (i.e., 20-39 years of age) had concentrations similar to adolescent girls and women 40 years of age. These population data on exposure to phthalates will serve an important role in public health by helping to set research priorities and by establishing a nationally representative baseline of exposure with which population levels can be compared.

Citing Articles

Moderating effects of insomnia on the association between urinary phthalate metabolites and depressive symptoms in Chinese college students: focus on gender differences.

Li T, Tao S, Jiang T, Che W, Zou L, Yang Y BMC Public Health. 2025; 25(1):802.

PMID: 40016718 PMC: 11869618. DOI: 10.1186/s12889-025-21986-z.


Molecular Mechanisms of Phthalate-Induced Hepatic Injury and Amelioration by Plant-Based Principles.

Singh L, Pandey R, Siddiqi N, Sharma B Toxics. 2025; 13(1).

PMID: 39853030 PMC: 11768991. DOI: 10.3390/toxics13010032.


Hair Straightener Use in Relation to Prevalent and Incident Fibroids in the Sister Study with a Focus on Black Women.

Ogunsina K, OBrien K, White A, Chang C, Gaston S, Jackson C Environ Health Perspect. 2025; 133(1):17004.

PMID: 39808082 PMC: 11730732. DOI: 10.1289/EHP14493.


Here's the Rub: Skin Care Products and Children's Phthalate Exposures.

Key L Environ Health Perspect. 2024; 132(12):124002.

PMID: 39666390 PMC: 11636779. DOI: 10.1289/EHP16068.


Management of phthalates in Canada and beyond: can we do better to protect human health?.

Renwick M, Bolling A, Shellington E, Rider C, Diamond M, Carlsten C Front Public Health. 2024; 12:1473222.

PMID: 39606079 PMC: 11599199. DOI: 10.3389/fpubh.2024.1473222.


References
1.
Pollack G, Buchanan J, Slaughter R, Kohli R, Shen D . Circulating concentrations of di(2-ethylhexyl) phthalate and its de-esterified phthalic acid products following plasticizer exposure in patients receiving hemodialysis. Toxicol Appl Pharmacol. 1985; 79(2):257-67. DOI: 10.1016/0041-008x(85)90347-3. View

2.
CHING N, Jham G, Subbarayan C, Grossi C, Hicks R, NEALON Jr T . Gas chromatographic quantitation of two plasticizers contaminating intravenous fluids stored in plastic containers. J Chromatogr. 1981; 225(1):196-201. DOI: 10.1016/s0378-4347(00)80260-1. View

3.
Dirven H, van den Broek P, Arends A, Nordkamp H, de Lepper A, Henderson P . Metabolites of the plasticizer di(2-ethylhexyl)phthalate in urine samples of workers in polyvinylchloride processing industries. Int Arch Occup Environ Health. 1993; 64(8):549-54. DOI: 10.1007/BF00517699. View

4.
Huber W, Grasl-Kraupp B, Schulte-Hermann R . Hepatocarcinogenic potential of di(2-ethylhexyl)phthalate in rodents and its implications on human risk. Crit Rev Toxicol. 1996; 26(4):365-481. DOI: 10.3109/10408449609048302. View

5.
Mettang T, Thomas S, Kiefer T, FISCHER F, Kuhlmann U, Wodarz R . Uraemic pruritus and exposure to di(2-ethylhexyl) phthalate (DEHP) in haemodialysis patients. Nephrol Dial Transplant. 1996; 11(12):2439-43. DOI: 10.1093/oxfordjournals.ndt.a027211. View